These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15173512)

  • 21. Cystic fibrosis newborn screening: using experience to optimize the screening algorithm.
    Hale JE; Parad RB; Dorkin HL; Gerstle R; Lapey A; O'Sullivan BP; Spencer T; Yee W; Comeau AM
    J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S255-61. PubMed ID: 20521170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newborn Screening for Cystic Fibrosis in California.
    Kharrazi M; Yang J; Bishop T; Lessing S; Young S; Graham S; Pearl M; Chow H; Ho T; Currier R; Gaffney L; Feuchtbaum L;
    Pediatrics; 2015 Dec; 136(6):1062-72. PubMed ID: 26574590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population.
    Corbetta C; Seia M; Bassotti A; Ambrosioni A; Giunta A; Padoan R
    J Med Screen; 2002; 9(2):60-3. PubMed ID: 12133923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neonatal screening for cystic fibrosis: comparing the performances of IRT/DNA and IRT/PAP.
    Sarles J; Giorgi R; Berthézène P; Munck A; Cheillan D; Dagorn JC; Roussey M
    J Cyst Fibros; 2014 Jul; 13(4):384-90. PubMed ID: 24513262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years' experience.
    Ranieri E; Lewis BD; Gerace RL; Ryall RG; Morris CP; Nelson PV; Carey WF; Robertson EF
    BMJ; 1994 Jun; 308(6942):1469-72. PubMed ID: 8019280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of IVS8-(TG)m(T)n on IRT and sweat chloride levels in newborns identified by California CF newborn screening.
    Keiles S; Koepke R; Parad R; Kharrazi M;
    J Cyst Fibros; 2012 May; 11(3):257-60. PubMed ID: 22209734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
    J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thirty-years of screening for cystic fibrosis in East Anglia.
    Calvin J; Hogg SL; McShane D; McAuley SA; Iles R; Ross-Russell R; MacLean FM; Heeley ME; Heeley AF;
    Arch Dis Child; 2012 Dec; 97(12):1043-7. PubMed ID: 23076339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis.
    Ranieri E; Ryall RG; Morris CP; Nelson PV; Carey WF; Pollard AC; Robertson EF
    BMJ; 1991 May; 302(6787):1237-40. PubMed ID: 2043846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Quantase neonatal immunoreactive trypsinogen (IRT) screening assay for cystic fibrosis.
    Ball CL; Montgomery MD; Bridge PJ; Lyon ME
    Clin Chem Lab Med; 2005; 43(5):570-2. PubMed ID: 15899682
    [No Abstract]   [Full Text] [Related]  

  • 31. Markedly elevated neonatal immunoreactive trypsinogen levels in the absence of cystic fibrosis gene mutations is not an indication for further testing.
    Massie J; Curnow L; Tzanakos N; Francis I; Robertson CF
    Arch Dis Child; 2006 Mar; 91(3):222-5. PubMed ID: 16243854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a New Newborn Screening Model for Cystic Fibrosis.
    Kharrazi M
    J Pediatr; 2016 Aug; 175():7-9. PubMed ID: 27255858
    [No Abstract]   [Full Text] [Related]  

  • 33. [The French nationwide cystic fibrosis newborn screening program: strategy and results].
    Munck A; Roussey M
    Arch Pediatr; 2008 Jun; 15 Suppl 1():S1-6. PubMed ID: 18822253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood concentrations of pancreatitis associated protein in neonates: relevance to neonatal screening for cystic fibrosis.
    Sarles J; Barthellemy S; Férec C; Iovanna J; Roussey M; Farriaux JP; Toutain A; Berthelot J; Maurin N; Codet JP; Berthézène P; Dagorn JC
    Arch Dis Child Fetal Neonatal Ed; 1999 Mar; 80(2):F118-22. PubMed ID: 10325788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood immunoreactive trypsinogen concentrations are genetically determined in healthy and cystic fibrosis newborns.
    Lecoq I; Brouard J; Laroche D; Férec C; Travert G
    Acta Paediatr; 1999 Mar; 88(3):338-41. PubMed ID: 10229049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis.
    Wells J; Rosenberg M; Hoffman G; Anstead M; Farrell PM
    Pediatrics; 2012 Feb; 129(2):e339-47. PubMed ID: 22291119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neonatal screening for cystic fibrosis].
    Tellería Orriols JJ; Alonso Ramos MJ; Garrote Adrados JA; Fernández Carvajal I; Blanco Quirós A
    An Esp Pediatr; 2002 Jul; 57(1):60-5. PubMed ID: 12139895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges in Cystic Fibrosis Newborn Screening and Recommendations for Primary Care Physicians.
    Sosnay PR; Farrell P
    Pediatrics; 2015 Dec; 136(6):1181-4. PubMed ID: 26574585
    [No Abstract]   [Full Text] [Related]  

  • 39. A new cystic fibrosis newborn screening algorithm: IRT/IRT1 upward arrow/DNA.
    Sontag MK; Wright D; Beebe J; Accurso FJ; Sagel SD
    J Pediatr; 2009 Nov; 155(5):618-22. PubMed ID: 19540513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newborn screening for cystic fibrosis in Switzerland--consequences after analysis of a 4 months pilot study.
    Torresani T; Fingerhut R; Rueegg CS; Gallati S; Kuehni CE; Baumgartner MR; Barben J;
    J Cyst Fibros; 2013 Dec; 12(6):667-74. PubMed ID: 23712087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.